Skip to main content

Advertisement

SpringerLink
Log in

Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ermis U, Weis J, Schulz JB (2013) PML in a patient treated with fumaric acid. N Engl J Med 368:1657–1658

    Article  CAS  PubMed  Google Scholar 

  2. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367:1098–1107

    Article  CAS  PubMed  Google Scholar 

  3. Koralnik IJ, Wuthrich C, Dang X, Rottnek M, Gurtman A, Simpson D, Morgello S (2005) JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 57:576–580

    Article  PubMed  Google Scholar 

  4. Kothary N, Diak IL, Brinker A, Bezabeh S, Avigan M, Dal Pan G (2011) Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J Am Acad Dermatol 65:546–551

    Article  CAS  PubMed  Google Scholar 

  5. Moenster RP, Jett RA (2012) Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. Am J Health Syst Pharm 69:496–498

    Article  CAS  PubMed  Google Scholar 

  6. Ryschkewitsch CF, Jensen PN, Major EO (2013) Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 57:243–248

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Sorensen PS, Bertolotto A, Edan G, Giovannoni G, Gold R, Havrdova E, Kappos L, Kieseier BC, Montalban X, Olsson T (2012) Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 18:143–152

    Article  PubMed  Google Scholar 

  8. Sweetser MT, Dawson KT, Bozic C (2013) Manufacturer’s response to case reports of PML. N Engl J Med 368:1659–1661

    Article  CAS  PubMed  Google Scholar 

  9. van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP (2013) PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med 368:1658–1659

    Article  PubMed  Google Scholar 

  10. Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826–1840

    Article  CAS  PubMed  Google Scholar 

  11. Wuthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A, Anderson MP, Ropper AH, Viscidi RP, Koralnik IJ (2009) Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 65:742–748

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

MS, ET, and FTB are funded in part, through TRM, by the German Federal Ministry of Education and Research (BMBF 1315883); otherwise, the report was funded by the authors’ institutions. This case has been presented, with the limited follow-up available then, as a poster at the Annual Meeting of the German Society of Neurology (DGN), Hamburg, Germany, September 2012.

Conflicts of interest

The authors have no financial or other personal associations with respect to procedures, products, or findings mentioned in this report which could impose a conflict of interest.

Ethical standards

Patient data were acquired during clinical care. The patient gave his written consent to report details as given in this manuscript.

Author information

Authors and Affiliations

  1. Department of Neurology, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany

    Muriel Stoppe, Eva Thomä, Joseph Claßen & Florian Then Bergh

  2. Department of Virology, University of Leipzig, Leipzig, Germany

    Uwe Gerd Liebert

  3. Translational Centre for Regenerative Medicine, University of Leipzig, Leipzig, Germany

    Muriel Stoppe, Eva Thomä & Florian Then Bergh

  4. Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

    Eugene O. Major

  5. Department of Neuroradiology, University of Leipzig, Leipzig, Germany

    Karl-Titus Hoffmann

Authors
  1. Muriel Stoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Thomä
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uwe Gerd Liebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eugene O. Major
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karl-Titus Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph Claßen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Florian Then Bergh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Then Bergh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoppe, M., Thomä, E., Liebert, U.G. et al. Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis. J Neurol 261, 1021–1024 (2014). https://doi.org/10.1007/s00415-014-7311-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-014-7311-1

Keywords

Search

Navigation